Table 1.

Characteristics of the study participants at baseline.

	Patients (n = 32)	Controls (n = 32)	p value
Gender (male/female)	16/16	21/11	0.21
Age (years)	30.94 ± 8.25	31.37 ± 7.84	0.83
Years of education (years)	12.13 ± 3.19	12.03 ± 2.38	0.89
FD (mm)	0.03 ± 0.02	0.03 ± 0.02	0.92
Illness duration (months)	8.91 ± 6.39
Dose of olanzapine at week 1 (mg/day)	12.19 ± 3.09
Dose of olanzapine at week 8 (mg/day)	18.59 ± 4.96

FD, framewise displacement.